Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parviz M Pour

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|June 23, 2005
High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitroTarek H El-Metwally, Mahmoud R Hussein, Parviz M Pour, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 19, 2002
Expression of drug-metabolizing enzymes in the pancreas of hamster, mouse, and rat, responding differently to the pancreatic carcinogenicity of BOPAlexis B Ulrich, Jens Standop, Bruno M Schmied, et al.
Oncology Reports|November 18, 2004
ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancerJens Standop, Matthias Schneider, Alexis Ulrich, et al.
Toxicologic Pathology|April 13, 2002
Species differences in the distribution of drug-metabolizing enzymes in the pancreasAlexis B Ulrich, Jens Standop, Bruno M Schmied, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2002
ErbB2 oncogene expression supports the acute pancreatitis-chronic pancreatitis sequenceJens Standop, Silke Standop, Atsushi Itami, et al.
Pancreas|June 24, 2004
The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growthFumiaki Nozawa, Atsushi Itami, Murat Saruc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cellsWei-Gang Tong, Xian-Zhong Ding, Rene Hennig, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|January 20, 2010
Pancreatic cancer and glucose metabolismMurat Saruç, Mehmet Karaarslan, Kemal Rasa, et al.
Journal of Toxicology and Environmental Health. Part A|October 25, 2002
The pattern of xenobiotic-metabolizing enzymes in the human pancreasJens Standop, Matthias B Schneider, Alexis Ulrich, et al.
The American Journal of Gastroenterology|October 13, 2006
MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implicationsMahefatiana Andrianifahanana, Subhash C Chauhan, Amit Choudhury, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|June 23, 2005
High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitroTarek H El-Metwally, Mahmoud R Hussein, Parviz M Pour, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 19, 2002
Expression of drug-metabolizing enzymes in the pancreas of hamster, mouse, and rat, responding differently to the pancreatic carcinogenicity of BOPAlexis B Ulrich, Jens Standop, Bruno M Schmied, et al.
Oncology Reports|November 18, 2004
ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancerJens Standop, Matthias Schneider, Alexis Ulrich, et al.
Toxicologic Pathology|April 13, 2002
Species differences in the distribution of drug-metabolizing enzymes in the pancreasAlexis B Ulrich, Jens Standop, Bruno M Schmied, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2002
ErbB2 oncogene expression supports the acute pancreatitis-chronic pancreatitis sequenceJens Standop, Silke Standop, Atsushi Itami, et al.
Pancreas|June 24, 2004
The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growthFumiaki Nozawa, Atsushi Itami, Murat Saruc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cellsWei-Gang Tong, Xian-Zhong Ding, Rene Hennig, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|January 20, 2010
Pancreatic cancer and glucose metabolismMurat Saruç, Mehmet Karaarslan, Kemal Rasa, et al.
Journal of Toxicology and Environmental Health. Part A|October 25, 2002
The pattern of xenobiotic-metabolizing enzymes in the human pancreasJens Standop, Matthias B Schneider, Alexis Ulrich, et al.
The American Journal of Gastroenterology|October 13, 2006
MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implicationsMahefatiana Andrianifahanana, Subhash C Chauhan, Amit Choudhury, et al.
Pageof 4